Health technology assessment (HTA)

HPI deploys highly specialized teams to help address current pharmaceutical reimbursement challenges including:

  • HTA dossier preparation
  • Cost effectiveness analysis (CEA) models and technical reports
  • Budget impact analysis (BIA) models and technical reports
  • Epidemiological studies
  • Cost of illness studies
  • Systematic Literature Reviews (SLRs) for comparative analysis